BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 36814688)

  • 41. The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants.
    Ao D; He X; Hong W; Wei X
    MedComm (2020); 2023 Apr; 4(2):e239. PubMed ID: 36938325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protopanaxadiol manipulates gut microbiota to promote bone marrow hematopoiesis and enhance immunity in cyclophosphamide-induced immunosuppression mice.
    Cao Y; Liu B; Li W; Geng F; Gao X; Yue L; Liu H; Liu C; Su Z; Lü J; Pan X
    MedComm (2020); 2023 Apr; 4(2):e222. PubMed ID: 36845073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphatidylserine decarboxylase downregulation in uric acid‑induced hepatic mitochondrial dysfunction and apoptosis.
    Liu N; Huang L; Xu H; He X; He X; Cao J; Xu W; Wang Y; Wei H; Wang S; Zheng H; Gao S; Xu Y; Lu W
    MedComm (2020); 2023 Aug; 4(4):e336. PubMed ID: 37502610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The double-edged role of neutrophil heterogeneity in inflammatory diseases and cancers.
    Zhou W; Cao X; Xu Q; Qu J; Sun Y
    MedComm (2020); 2023 Aug; 4(4):e325. PubMed ID: 37492784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Applications of multi-omics analysis in human diseases.
    Chen C; Wang J; Pan D; Wang X; Xu Y; Yan J; Wang L; Yang X; Yang M; Liu GP
    MedComm (2020); 2023 Aug; 4(4):e315. PubMed ID: 37533767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression.
    Yan B; Guo J; Wang Z; Ning J; Wang H; Shu L; Hu K; Chen L; Shi Y; Zhang L; Liu S; Tao Y; Xiao D
    MedComm (2020); 2023 Aug; 4(4):e337. PubMed ID: 37492786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial.
    Yin J; Yuan J; Li Y; Fang Y; Wang R; Jiao H; Tang H; Zhang S; Lin S; Su F; Gu J; Jiang T; Lin D; Huang Z; Du C; Wu K; Tan L; Zhou Q
    Nat Med; 2023 Aug; 29(8):2068-2078. PubMed ID: 37488287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TRAF6 regulates autophagy and apoptosis of melanoma cells through c-Jun/ATG16L2 signaling pathway.
    Guo Y; Zhang X; Li J; Zhou Z; Zhu S; Liu W; Su J; Chen X; Peng C
    MedComm (2020); 2023 Aug; 4(4):e309. PubMed ID: 37484971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of hypoxia in cellular senescence.
    Gao H; Nepovimova E; Heger Z; Valko M; Wu Q; Kuca K; Adam V
    Pharmacol Res; 2023 Aug; 194():106841. PubMed ID: 37385572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.
    Chen T; Cheng L; Ma J; Yuan J; Pi C; Xiong L; Chen J; Liu H; Tang J; Zhong Y; Zhang X; Liu Z; Zuo Y; Shen H; Wei Y; Zhao L
    Pharmacol Res; 2023 Aug; 194():106837. PubMed ID: 37379962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Astrocyte-derived extracellular vesicles in stress-associated mood disorders. Does the immune system get astrocytic?
    Luarte A; Nardocci G; Chakraborty A; Batiz LF; Pino-Lagos K; Wyneken Ú
    Pharmacol Res; 2023 Aug; 194():106833. PubMed ID: 37348692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical mitophagy modulators: Drug development strategies and novel regulatory mechanisms.
    Dong Y; Zhuang XX; Wang YT; Tan J; Feng D; Li M; Zhong Q; Song Z; Shen HM; Fang EF; Lu JH
    Pharmacol Res; 2023 Aug; 194():106835. PubMed ID: 37348691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sanggenon C inhibits cell proliferation and induces apoptosis by regulating the MIB1/DAPK1 axis in glioblastoma.
    Chang H; Hou J; Shao Y; Xu M; Weng X; Du Y; Shi J; Zhang L; Cui H
    MedComm (2020); 2023 Aug; 4(4):e281. PubMed ID: 37346933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T-cell lymphoma.
    Wang Y; Zhou W; Chen J; Chen J; Deng P; Chen H; Sun Y; Yu Z; Pang D; Liu L; Wang P; Hong JH; Teh BT; Huang H; Li W; Yi Z; Lim ST; Chen Y; Ong CK; Liu M; Tan J
    MedComm (2020); 2023 Aug; 4(4):e284. PubMed ID: 37334274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay.
    Fan X; Meng M; Li B; Chen H; Tan J; Xu K; Xiao S; Kwan HY; Liu Z; Su T
    J Transl Med; 2023 Apr; 21(1):260. PubMed ID: 37062842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer.
    Liu Y; Sun Y; Wang P; Li S; Dong Y; Zhou M; Shi B; Jiang H; Sun R; Li Z
    J Transl Med; 2023 Apr; 21(1):255. PubMed ID: 37046312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIGD2A silencing impairs hepatocellular carcinoma growth via inhibiting mitochondrial function and the MAPK/ERK pathway.
    Huang K; Liu Z; Xie Z; Li X; Zhang H; Chen Y; Wang Y; Lin Z; Li C; Liu H; Zhang X
    J Transl Med; 2023 Apr; 21(1):253. PubMed ID: 37041638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inactivation of
    Li Y; Wu D; Li H; Sun Y
    MedComm (2020); 2023 Aug; 4(4):e332. PubMed ID: 37470067
    [No Abstract]   [Full Text] [Related]  

  • 59. SIK3-HDAC4 signaling pathway: the switch for transition between sleep and wakefulness.
    Tu Y; Zhou F; Zhang L
    Mol Biomed; 2023 Jul; 4(1):20. PubMed ID: 37400747
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacological inhibiting STAT5 for the treatment of FLT3-ITD-positive acute myeloid leukemia with triciribine phosphate monohydrate.
    Wu H; Ge J; Zou F; Jiang Z; Wang B; Yuan X; Long K; Liu J; Wang W; Liu Q
    MedComm (2020); 2023 Aug; 4(4):e294. PubMed ID: 37361897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.